- Home
- IVD
- By Technology Types
- By Diseases Types
- By Product Types
- Research
- Resource
- Distributors
- Company
| Product Name | Animal-Free Bionic Matrix Powder, Type III, Lyophilized |
| Catalog No. | RERE-0114 |
| Description | A component-defined network scaffold powder assembled from bio-derived materials and supplied lyophilised. Unlike animal tissue extracts and crosslinked hydrogels, the formulation is fully biocompatible and free of animal-origin components and cytotoxic crosslinking agents; its constituents self-assemble into a network within the culture system and can be covalently modified with cell-adhesive sequences such as RGD. The result mimics the native extracellular matrix in material properties, microarchitecture and function, recreating in vitro a microenvironment comparable to that experienced by cells in tissue. Sterile, endotoxin-free and mycoplasma-free. |
| Intended Use | Building defined ECM-mimetic microenvironments for cell culture, including RGD-functionalised variants |
| Principle / Technology | Self-assembly of bio-derived constituents into an ECM-like network covalently modifiable with adhesion sequences |
| Sample Type | Cell culture systems requiring defined, animal-free scaffolds |
| Specificity | Component-defined; animal-origin free; sterile; endotoxin-free; mycoplasma-free; type III |
| Reaction Conditions / Protocol | Reconstitute the lyophilised powder under aseptic conditions and incorporate into the culture system |
| Storage Conditions | 2 to 8°C |
| Package Specifications | 15 mg |
| Key Features | Lyophilised format simplifies shipping and storage; defined composition supports reproducibility |
For research use only, not for clinical use.
|
There is no product in your cart. |